Key Insights

Highlights

Treatment Research

3 treatments under study, led by Dexamethasone

Research Leaders

5 sponsors active, led by Shaanxi Provincial Cancer Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07254416Phase 4Not Yet RecruitingPrimary

A Study on Nausea and Vomiting Caused by T-DXd in Breast Cancer Patients

Showing all 1 trials

Research Network

Common Treatments

  • Dexamethasone1
  • Megestrol Acetate1
  • Nepa1

Active Sponsors

  • Shaanxi Provincial Cancer Hospital1
  • Shanxi Bethune Hospital1
  • The First Affiliated Hospital of Henan University of Science and Technology1
  • Tianjin Cancer Hospital Airport Hospital1
  • Tianjin Medical University Cancer Institute and Hospital1

Activity Timeline